Business
Infant Bacterial Therapeutics Q3 Operating Loss SEK 48.5 Mln
Infant Bacterial Therapeutics Q3 Operating Loss SEK 48.5 Mln
About this update from Infant Bacterial Therapeutics Ab Class B
Infant Bacterial Therapeutics AB OMXSTO:IBT_B:Q3 NET SALES SEK 0 THOUSANDQ3 OPERATING PROFIT SEK -48,457 THOUSAND
View stock analysis, news, and events for Infant Bacterial Therapeutics Ab Class B